Brief: PLX Pharma Q3 Earnings Per Share $0.09
08/11/2019 11:55
Nov 8 (Reuters) - PLx Pharma Inc PLXP.O :
* REPORTS THIRD QUARTER 2019 RESULTS
* Q3 EARNINGS PER SHARE $0.09
* AS OF SEPTEMBER 30, 2019, COMPANY HAD CASH AND CASH
EQUIVALENTS
OF $18.5 MILLION.
* TRACKING ON ALL SIGNIFICANT MILESTONES, WITH GOAL OF
LAUNCHING
VAZALORE IN MID-2020
Source text for Eikon: ID:nGNXrNnBQ
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice